EN | RU
EN | RU

Help Support

Back

Safety of noninvasive treatment for uterine fibroids on pregnancy

Safety of noninvasive treatment for uterine fibroids on pregnancy Safety of noninvasive treatment for uterine fibroids on pregnancy
Safety of noninvasive treatment for uterine fibroids on pregnancy Safety of noninvasive treatment for uterine fibroids on pregnancy

This retrospective observational study was carried out to study the effect of USgHIFU ablation for uterine fibroids in women, including those with a history of infertility.

See All

Key take away

Ultrasound-guided high-intensity focused ultrasound (USgHIFU) treatment may be a safe and effective approach for fibroids in females with a desire to experience pregnancy, together with those with a past of infertility. It can help achieve full-term pregnancies with hardly any perinatal issues and no extra obstetric risks.

Background

This retrospective observational study was carried out to study the effect of USgHIFU ablation for uterine fibroids in women, including those with a history of infertility.

Method

Overall, 560 females of reproductive age having uterine fibroids and underwent USgHIFU therapy considered. The pregnancy outcomes, for example, conception time, gestational age, delivery mode, neonatal outcomes and issues during pregnancy and delivery, were all noted.

Result

There were 71 pregnancies (82% natural; 18% in vitro fertilized [IVF]) in 55 females following USgHIFU therapy. The median time to conception was 12 months. There were 43 (61%) successful deliveries, counting a twin pregnancy, 22 natural miscarriages and 6 therapeutic abortions. The rate of premature deliveries was very low (9%) compared to full-term deliveries (91%).

Out of 44 live births (birth weight of 3.1 ± 0.6 kg on an average), 25 (57%) were vaginal deliveries, and 19 (43%) was by C-section. About 7% of females reported retained placenta, 5% with placenta previa and 2% with acute preeclampsia. There were complications reported in newborns during postpartum and breastfeeding, excluding 1 baby born with tetralogy of Fallot.

Conclusion

A healthy and full-term pregnancy can be achieved in females undertaking USgHIFU ablation therapy of uterine fibroids with very few intrapartum or postpartum issues.

Source:

International Journal of Hyperthermia

Article:

Pregnancy outcomes after ultrasound-guided high-intensity focused ultrasound (USgHIFU) for conservative treatment of uterine fibroids: experience of a single institution

Authors:

J. Rodríguez et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru ua
Try: